These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29687694)

  • 1. Emerging from gastroesophageal reflux (EMERGE): An Italian survey - II the viewpoint of the patient.
    Bianchetti M; Peralta S; Nicita R; Aragona SE; Ciprandi G;
    J Biol Regul Homeost Agents; 2018; 32(4):983-988. PubMed ID: 29687694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging from gastroesophageal reflux (EMERGE): an Italian survey - I the viewpoint of the gastroenterologist.
    Bianchetti M; Peralta S; Nicita R; Aragona SE; Ciprandi G;
    J Biol Regul Homeost Agents; 2018; 32(4):973-981. PubMed ID: 29687693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relieving laryngopharingeral reflux (RELIEF) survey in otolaryngology - II the viewpoint of the patient.
    Gelardi M; Silvestri M; Ciprandi G;
    J Biol Regul Homeost Agents; 2018 Jan-Feb,; 32(1 Suppl. 2):21-28. PubMed ID: 29436211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric reflux: the therapeutical role of Marial® .
    Aragona SE; Mereghetti G; Ciprandi G
    J Biol Regul Homeost Agents; 2018; 32(4):969-972. PubMed ID: 29687692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
    Miyamoto M; Manabe N; Haruma K
    Intern Med; 2010; 49(15):1469-76. PubMed ID: 20686276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
    Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
    J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the reflux finding score and the GERD impact scale in patients with gastroesophageal reflux disease.
    Bianchetti M; Peralta S; Nicita R; Aragona SE; Ciprandi G;
    J Biol Regul Homeost Agents; 2018; 32(4):989-993. PubMed ID: 29687695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?].
    Labenz J; Labenz G; Stephan D; Willeke F;
    MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial.
    Foocharoen C; Chunlertrith K; Mairiang P; Mahakkanukrauh A; Suwannaroj S; Namvijit S; Wantha O; Nanagara R
    Rheumatology (Oxford); 2017 Feb; 56(2):214-222. PubMed ID: 27179107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of treatment pattern and symptom control in patients with gastroesophageal reflux disease: multihospital questionnaire survey on the current situation in Korea.
    Seo SI; Bang CS; Kang HS; Choi MH; Shin WG; Jang HJ; Kim JB; Baik KH; Kae SH; Kim HY
    Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
    Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
    J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific survey.
    Goh KL; Choi MG; Hsu WP; Chun HJ; Mahachai V; Kachintorn U; Leelakusolvong S; Kim N; Rani AA; Wong BC; Wu J; Chiu CT; Chu R; Shetty V; Bocobo JC; Chan MM; Lin JT
    J Gastroenterol Hepatol; 2014 Dec; 29(12):1969-75. PubMed ID: 24990817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough.
    Kiljander TO
    Am J Med; 2003 Aug; 115 Suppl 3A():65S-71S. PubMed ID: 12928078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
    Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Online follow-up of individuals with gastroesophageal reflux disease using a patient-reported outcomes instrument: results of an observational study.
    Tielemans MM; van Oijen MG
    BMC Gastroenterol; 2013 Oct; 13():144. PubMed ID: 24083342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists.
    Pasta A; Pelizzaro F; Marabotto E; Calabrese F; Formisano E; Djahandideh Sheijani S; Brandimarte G; Manes G; Gravina AG; Savarino EV
    Therap Adv Gastroenterol; 2024; 17():17562848241239590. PubMed ID: 38524789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.